Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/43773
Title: Pharmacogenetic testing: Legal considerations for consent, privacy and disclosure
Authors: Romeo Malanda, Sergio 
Nicol, Dianne
UNESCO Clasification: 32 Ciencias médicas
Keywords: Consent
Disclosure
Duty of confidentiality
Exceptional circumstances
Pharmacogenetic testing, et al
Issue Date: 2008
Publisher: 1741-0541
Journal: Personalized Medicine 
Abstract: This review provides an overview of the European legal framework relating to the protection of sensitive data obtained from pharmacogenetic tests. The primary objective of pharmacogenetic testing is neither diagnosis nor prediction of disease, but determining likely responses to medicines based on specific genetic factors. Nevertheless, pharmacogenetic testing can lead to the disclosure of sensitive information and, as a consequence, it is argued that consent is a prerequisite. It is further argued that appropriate protection for privacy and confidentiality is crucial, but that disclosure may be justified in certain exceptional circumstances. This article describes the various European legislative instruments that provide useful guidance on the types of circumstances when disclosure may be justified.
URI: http://hdl.handle.net/10553/43773
ISSN: 1741-0541
DOI: 10.2217/17410541.5.2.155
Source: Personalized Medicine [ISSN 1741-0541], v. 5, p. 155-161
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

3
checked on Jun 13, 2021

Page view(s)

5
checked on Jun 13, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.